Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Novel Self-Nano-Emulsifying Drug Delivery System Bearing Docetaxel with Enhanced Bioavailability and Anticancer in Experimental Breast Cancer Model
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Poster
- By: MEHER, Jaya Gopal (CSIR- Central Drug Research Institute, Pharmaceutics, Lucknow, India)
- Co-author(s): Jaya Gopal Meher: Pharmaceutics, CSIR- Central Drug Research Institute, Lucknow, India
Manish Chourasia: Pharmaceutics, CSIR- Central Drug Research Institute, Lucknow, India
BackgroundsDocetaxel is a popular anticancer drug, but its marketed formulations are associated with hypersensitivity and neurotoxicity.
AimsPresent work is directed towards improvement of oral bio-availability and anticancer effect of docetaxel employing a novel self-nano-emulsifying drug delivery system (SNEDDS).
MethodsSNEDDS bearing docetaxel.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019